Background The rapid diagnosis of Coronavirus Disease 2019 (COVID-19) patients is
essential to reduce the disease spread. Rapid antigen detection (RAD) tests are available …

Background Numerous rapid antigen detection (RAD) kits for diagnosing COVID-19 patients
are available in the market recently. Objective To compare analytical sensitivity and clinical …

Background Currently, there are two rapid antigen detection (RAD) kits from the WHO
Emergency Use List for detecting SARS-CoV-2. Objective The Panbio COVID-19 Ag Rapid …

Background Early diagnosis of the novel coronavirus disease of 2019 (COVID-19) in
asymptomatic and symptomatic patients is crucial to identify infectious individuals and to …

The identification and isolation of highly infectious SARS-CoV-2-infected individuals is an
important public health strategy. Rapid antigen detection tests (RADT) are promising tools …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can spread
from symptomatic patients with COVID-19, but also from asymptomatic individuals …

Background Early diagnosis of SARS-CoV-2 infection is essential to reduce disease spread.
Rapid antigen tests have not been sufficiently evaluated in asymptomatic patients to be used …

There is an ongoing need for reliable antigen assays for timely and easy detection of
individuals with acute SARS-CoV-2 infection. Using 75 swabs from patients previously …

Due to globally rising numbers of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infections, resources for real-time reverse-transcription polymerase chain reaction …

Diagnostics is crucial for a prompt identification of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) infected patients, their isolation and treatment. Real‐time PCR …